Dexmedetomidine alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury in mice
Authors:
- 1 July 2019
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 72, 367-373
Abstract
No abstract availableKeywords
Funding Information
- Major Science and Technology Plan (2018YFZD008)
This publication has 39 references indexed in Scilit:
- Tumor Necrosis Factor-αand Interleukin-6: Potential Interorgan Inflammatory Mediators Contributing to Destructive Periodontal Disease in Obesity or Metabolic SyndromeMediators of Inflammation, 2013
- The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseasesHepatology International, 2010
- Pathological roles of MAPK signaling pathways in human diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Role of the perforin/granzyme cell death pathway ind-Gal/LPS-induced inflammatory liver injuryAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- JNK signaling in apoptosisOncogene, 2008
- Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1Proceedings of the National Academy of Sciences, 2008
- Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-α induced apoptosisApoptosis, 2006
- Mitogen-activated protein kinases in apoptosis regulationOncogene, 2004
- Role of FAN in Tumor Necrosis Factor-α and Lipopolysaccharide-induced Interleukin-6 Secretion and Lethality in d-Galactosamine-sensitized MiceJournal of Biological Chemistry, 2004
- Cell death and neuroprotection in Parkinson's diseaseNeurobiology of Aging, 2000